Studies people with many colorectal polyps to guide screening and genetic testing
Studies patients with multiple bowel adenomas, examining their features and genetic causes in adults.
Plain-language title generated from the registry record
Registry title: Clinical and Endoscopic Characterization of Patients With Multiple Colorectal Adenomas: A Multicenter Study in Spain (ESPAPOLYP Study)
Key facts
- Where
- Madrid, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have had 10 or more adenomas (growths) found in the colon or rectum.
- Age
- Over 18 years (minimum age 18 years).
- Sex
- All sexes can join.
- Disease stage
- 10 or more colorectal adenomas.
Main reasons for not taking part
- Inherited conditions
- Inflammatory bowel disease
Read by machine on 12 November 2026.
Where in Spain
- Asociacion Española de GastroenterologuaMadrid, SpainContact: GORETTI HERNANDEZ, PINo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Asociación Española de Gastroenterología
- Trial code
- NCT06625788
- Record updated
- 3 October 2024
- Original description
The aim is to clinically, endoscopically, and molecularly characterize patients with multiple colorectal adenomas, establish the indication for genetic testing to rule out hereditary syndromes and identify the genes to be included, and improve endoscopic screening recommendations for these patients and their relatives.Read full original descriptionShow less
CARACTERIZACIÓN CLÍNICA Y ENDOSCÓPICA DE PACIENTES CON MÚLTIPLES ADENOMAS COLORRECTALES: ESPAPOLIP
The aim is to clinically, endoscopically, and molecularly characterize patients with multiple colorectal adenomas, establish the indication for genetic testing to rule out hereditary syndromes and identify the genes to be included, and improve endoscopic screening recommendations for these patients and their relatives.
Inclusion: 10 or more adenomas; \>18 years.
Exclusion: Inflammatory bowel disease; Inhereted condictions.